ArticleScientific reports2023

Assessments of therapeutic effects according to timings for combined therapy with axitinib and immune check point inhibitor in a mouse renal cell carcinoma model.

Hiromitsu Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.